Covered recipient · General Payments record
JAROD F BAILEY
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$3,412.15
- Reported across 218 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $352.47 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Nevro Corp. | $92.28 | 1 |
| Stryker Corporation | $68.86 | 1 |
| Novo Nordisk AS | $39.62 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $34.49 | 1 |
| Lilly USA, LLC | $31.17 | 2 |
| Otsuka America Pharmaceutical, Inc. | $29.84 | 1 |
| DEXCOM, INC. | $21.99 | 1 |
| Astellas Pharma US Inc | $19.56 | 1 |
| Axsome Therapeutics, Inc. | $14.66 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $19.56 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139299524 | CMS |
| Axsome Therapeutics, Inc. | $14.66 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148288350 | CMS |
| Dexcom, Inc. | $21.99 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153306645 | CMS |
| Lilly USA, LLC | $17.72 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135028840 | CMS |
| Lilly USA, LLC | $13.45 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135029416 | CMS |
| Nevro Corp. | $92.28 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130765482 | CMS |
| Novartis Pharmaceuticals Corporation | $34.49 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086698055 | CMS |
| Novo Nordisk Inc | $23.65 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097151592 | CMS |
| Novo Nordisk Inc | $15.97 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096570848 | CMS |
| Otsuka America Pharmaceutical, Inc. | $29.84 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118857245 | CMS |
| Stryker Corporation | $68.86 | 06/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119767304 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.